Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear TBN Q1 2026 Earnings EPS Miss Reflects Exploration Costs and No Revenue Generation Afya Limited Q1 2026 Earnings EPS Misses Estimates Amid Steady Operations LEVI Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution NVDA Q1 2026 Earnings Strong EPS Beat Amid Market Caution AREN Q1 2026 Earnings Significant EPS Miss Despite Share Price Uptick